864
Views
0
CrossRef citations to date
0
Altmetric
Research Article

p14ARF ameliorates inflammation and airway remodeling in nitric acid aerosol inhalation-induced bronchiolitis obliterans

Pages 27-38 | Received 29 Aug 2022, Accepted 22 Dec 2022, Published online: 09 Jan 2023

References

  • Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr Opin Pediatr. 2008;20(3):272–278. doi:10.1097/MOP.0b013e3282ff62e9.
  • Colom AJ, Teper AM, Vollmer WM, Diette GB. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax. 2006;61(6):503–506. doi:10.1136/thx.2005.044909.
  • Cullinan P, Bush A. Growing old(er) with postinfectious bronchiolitis obliterans. Thorax. 2015;70(2):103–104. doi:10.1136/thoraxjnl-2014-206168.
  • Hertz MI, Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant. 2002;21(9):950–970. doi:10.1016/S1053-2498(02)00498-9.
  • Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168(11):1277–1292. doi:10.1164/rccm.200301-053SO.
  • King TE.Jr. Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic. Semin Respir Crit Care Med. 2003;24(5):567–576. doi:10.1055/s-2004-815604.
  • Yousem SA. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol. 1990;21(5):467–474. doi:10.1016/0046-8177(90)90002-m.
  • Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report–2007. J Heart Lung Transplant. 2007;26(8):769–781. doi:10.1016/j.healun.2007.06.004.
  • Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T, Nakao K. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. J Gastroenterol. 2004;39(4):355–361. doi:10.1007/s00535-003-1302-9.
  • Sharpless NE. INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res. 2005;576(1–2):22–38. doi:10.1016/j.mrfmmm.2004.08.021.
  • Muer A, Overkamp T, Gillissen B, et al. p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins. J Biol Chem. 2012;287(21):17343–17352. doi:10.1074/jbc.M111.314898.
  • Weber JD, Jeffers JR, Rehg JE, et al. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 2000;14(18):2358–2365. 2 doi:10.1101/gad.827300.
  • Ozenne P, Eymin B, Brambilla E, Gazzeri S. The ARF tumor suppressor: structure, functions and status in cancer. Int J Cancer. 2010;127(10):2239–2247. doi:10.1002/ijc.25511.
  • Saito K, Takigawa N, Ohtani N, et al. Antitumor impact of p14ARF on gefitinib-resistant non-small cell lung cancers. Mol Cancer Ther. 2013;12(8):1616–1628. doi:10.1158/1535-7163.MCT-12-1239.
  • Zhang H, Nie W, Huang F. The correlation relationship between P14ARF Gene DNA methylation and primary liver cancer. Med Sci Monit. 2015;21:3077–3082. doi:10.12659/MSM.894395.
  • Huang SJ, Li ZL, Ma XL, Du B, Wang JL. TREML4: a potential target for immunotherapy of sepsis. Discov Med. 2021;32(166):87–92.
  • Walker NM, Belloli EA, Stuckey L, et al. Mechanistic target of rapamycin complex 1 (mTORC1) and mTORC2 as key signaling intermediates in mesenchymal cell activation. J Biol Chem. 2016;291(12):6262–6271. doi:10.1074/jbc.M115.672170.
  • Hamilton G, Abraham AG, Morton J, et al. AKT regulates NPM dependent ARF localization and p53mut stability in tumors. Oncotarget. 2014;5(15):6142–6167. doi:10.18632/oncotarget.2178.
  • Liu KW, Feng H, Bachoo R, et al. SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest. 2011;121(3):905–917. doi:10.1172/JCI43690.
  • Institute of Laboratory Animal Resources (US). Committee on Care, & Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 2011.
  • Yin J, Ma X, Huang F, Ma Y, Li Y. Bronchiolitis obliterans murine model induced by nitric acid aerosol inhalation: an economical and reproducible model. Exp Lung Res. 2018;44(3):143–152. doi:10.1080/01902148.2018.1455926.
  • Costa CL, Spilborghs GM, Martins MA, Saldiva PH, Mauad T. Nitric acid-induced bronchiolitis in rats mimics childhood bronchiolitis obliterans. Respiration. 2005;72(6):642–649. doi:10.1159/000087363.
  • Ege T, Huseyin G, Yalcin O, Us MH, Arar C, Duran E. Importance of pulmonary artery perfusion in cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18(2):166–174. doi:10.1053/j.jvca.2004.01.022.
  • Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest. 2002;122(5):1543–1552. doi:10.1378/chest.122.5.1543.
  • Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol. 1999;104(2):356–363. doi:10.1016/S0091-6749(99)70379-9.
  • Gozal D. Post-infectious bronchiolitis obliterans in children: is general quality of life the right measure? J Pediatr (Rio J). 2018;94(4):340–341. doi:10.1016/j.jped.2018.01.001.
  • Gan CT, Ward C, Meachery G, Lordan JL, Fisher AJ, Corris PA. Long-term effect of azithromycin in bronchiolitis obliterans syndrome. BMJ Open Respir Res. 2019;6(1):e000465. doi:10.1136/bmjresp-2019-000465.
  • Corris PA, Ryan VA, Small T, et al. A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. Thorax. 2015;70(5):442–450. doi:10.1136/thoraxjnl-2014-205998.
  • Bergeron A, Chevret S, Chagnon K, et al. Budesonide/formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2015;191(11):1242–1249. doi:10.1164/rccm.201410-1818OC.
  • Kim SW, Rhee CK, Kim YJ, Lee S, Kim HJ, Lee JW. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Respir Res. 2016;17(1):63. doi:10.1186/s12931-016-0380-1.
  • Armand P, Gannamaneni S, Kim HT, et al. Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning. J Clin Oncol. 2008;26(35):5767–5774. doi:10.1200/JCO.2008.17.7279.
  • Sharma G, Mirza S, Prasad CP, Srivastava A, Gupta SD, Ralhan R. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci. 2007;80(20):1873–1881. doi:10.1016/j.lfs.2007.02.026.
  • Lu N, Yang Y, Liu H, et al. Inhibition of respiratory syncytial virus replication and suppression of RSV-induced airway inflammation in neonatal rats by colchicine. 3 Biotech. 2019;9(11):392. doi:10.1007/s13205-019-1917-z.
  • Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P. TGF-beta-induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci. 2017;18(10):2157. doi:10.3390/ijms18102157.
  • Jolly MK, Ward C, Eapen MS, et al. Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease. Dev Dyn. 2018;247(3):346–358. doi:10.1002/dvdy.24541.
  • Semenza GL. Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization. J Investig Med. 2016;64(2):361–363. doi:10.1097/JIM.0000000000000206.
  • Swatek AM, Lynch TJ, Crooke AK, et al. Depletion of airway submucosal glands and TP63(+)KRT5(+) basal cells in obliterative bronchiolitis. Am J Respir Crit Care Med. 2018;197(8):1045–1057. doi:10.1164/rccm.201707-1368OC.
  • Wang XX, Jiang LL. Silencing PDCD10 protects the uterus against ischemia/reperfusion injury by inhibiting fibrosis, inflammation and apoptosis in rats. J Biol Regul Homeost Agents. 2022;36(3):711–720.
  • Jin H, Cai W, Yu D, Fan J, Liu Q, Yu J. Development of proliferative vitreoretinopathy is attenuated by chicken ovalbumin upstream promoter transcriptional factor 1 via inhibiting epithelial-mesenchymal transition. Discov Med. 2022;34(172):103–113.
  • Wu Y, Deng H, Sun J, Xu Y. Isoquercitrin alleviates inflammation in diabetic nephropathy by inhibiting TLR4/NF-κB signaling pathway. J Biol Regul Homeost Agents. 2022;36(2):339–351.
  • Kennedy VE, Todd JL, Palmer SM. Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome. Am J Transplant. 2013;13(3):552–561. doi:10.1111/ajt.12091.
  • Liu X, Yue Z, Yu J, et al. Proteomic characterization reveals that MMP-3 correlates with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell and lung transplantation. Am J Transplant. 2016;16(8):2342–2351. doi:10.1111/ajt.13750.